![Logo of the public company MorphoSys displayed on a computer screen in close-up. Credit: PIXDUCE Stock Photo - Alamy Logo of the public company MorphoSys displayed on a computer screen in close-up. Credit: PIXDUCE Stock Photo - Alamy](https://c8.alamy.com/comp/2A8R53N/logo-of-the-public-company-morphosys-displayed-on-a-computer-screen-in-close-up-credit-pixduce-2A8R53N.jpg)
Logo of the public company MorphoSys displayed on a computer screen in close-up. Credit: PIXDUCE Stock Photo - Alamy
MorphoSys Pharma's Double Deal: Buys Constellation and Enters Partnership with Royalty Pharma | BioSpace
![MorphoSys AG General Corporate Statement By Foreign Issuer (Form6) - MorphoSys (NASDAQ:MOR), MorphoSys (OTC:MPSYF) - Benzinga MorphoSys AG General Corporate Statement By Foreign Issuer (Form6) - MorphoSys (NASDAQ:MOR), MorphoSys (OTC:MPSYF) - Benzinga](https://www.sec.gov/Archives/edgar/data/1340243/000162828023011861/a230418_exhibit991001.jpg)
MorphoSys AG General Corporate Statement By Foreign Issuer (Form6) - MorphoSys (NASDAQ:MOR), MorphoSys (OTC:MPSYF) - Benzinga
![Asgard Invest on Twitter: "Here the market cap of some of the largest biotech companies in the EU 🇪🇺 It includes Grifols $GRF.MC 🇪🇸, Novozymes $NZYMB.CO 🇩🇰, Chr. Hansen $CHR.CO 🇩🇰, Genmab $ Asgard Invest on Twitter: "Here the market cap of some of the largest biotech companies in the EU 🇪🇺 It includes Grifols $GRF.MC 🇪🇸, Novozymes $NZYMB.CO 🇩🇰, Chr. Hansen $CHR.CO 🇩🇰, Genmab $](https://pbs.twimg.com/media/DwhgFt1WwAAdnMA.jpg:large)